Barrett's Esophagus and associations with esophageal mucosal Injuries

Introduction: Columnar epithelium in the distal esophagus and biopsies with intestinal metaplasia define Barrett's esophagus (EB). The objective was to identify the association of EB and esophageal mucosa lesions in histopathological reports. Methods: a retrospective and cross-sectional study w...

Descripción completa

Detalles Bibliográficos
Autores: Lucchesi, Carolina Basílio, Morais , Vanessa Maria Oliveira, Trindade, Yasmin Tourinho Delmondes, Macedo, Victor Ravel Santos, Moura, Elomar Rezende, Melo, Durval José de Santana, Moreira, Larissa Gonçalves, Barreto, Íkaro Daniel de Carvalho, Silva, Décio Fragata da, Trindade, Leda Maria Delmondes Freitas
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:Brasil
Institución:Universidade Federal de Itajubá (UNIFEI)
Repositorio:Research, Society and Development
Idioma:portugués
OAI Identifier:oai:ojs.pkp.sfu.ca:article/28642
Acceso en línea:https://rsdjournal.org/index.php/rsd/article/view/28642
Access Level:acceso abierto
Palabra clave:Barrett's Esophagus
Mucosal Lesions
Metaplasia
Esophagitis.
Esófago de Barrett
Lesiones Mucosas
Esofagitis.
Esôfago de Barrett
Lesões de mucosa
Esofagite.
Descripción
Sumario:Introduction: Columnar epithelium in the distal esophagus and biopsies with intestinal metaplasia define Barrett's esophagus (EB). The objective was to identify the association of EB and esophageal mucosa lesions in histopathological reports. Methods: a retrospective and cross-sectional study with 1953 reports of esophageal mucosa. Results: 1953 biopsies of esophageal mucosa lesions were analyzed. We identified 133 (6.8%) of Barrett's esophagus, 151 (7.7%) with H.pylori and of these, 17 (11.3%) (p =0.041) were associated with Barrett's esophagus. The mean age group was 52 years old (IQR 42.5-62.5), male prevalence (63.2%). Lesions associated with EB: metaplasia 23 (17.3%) (p=0.004); dysplasia 8 (6%) (p<0.001), and 8 (100%) had low-grade dysplasia (p<0.001) and esophagitis with 34 (25.6%) reports, 33 (97%) of the chronic type . No association with malignancy was identified. As for the gross and adjusted relative risks, the following were significant: age (RR: 1.03 (95%CI: 1.02-1.04)) and RRa (95%CI) 1.03 (1.02-1.03), male sex, RR (95%CI) 1.76 (1.25-2.48) and RRa (95%CI) 1.03 (1.02-1.03) and dysplasia. Esophagitis, metaplasia and eosinophilic esophagitis were not likely to be at risk. There was a high probability of carcinogenic exposure regarding dysplasia (p=0.002) RR 5.83 (3.29-10.32), RRa 2.63 (1.45-4.78). Esophagitis was diagnosed in 1,416 reports of the total sample. When correlating with metaplasia, it was statistically significant (RR: 1.27; 95%CI: 1.14-1.42). Conclusion: male patients over 50 years of age with dysplasia and absence of esophagitis had a higher risk of Barrett's esophagus. Those who had metaplasia and eosinophils >=15 eos/AGC without lesions glycogenic acanthosis and polyps were at risk for esophagitis. The presence of metaplasia alone did not represent a risk factor for EB, although esophagitis seems to represent a greater risk for the development of metaplasia. Low-grade dysplasia was associated with a high carcinogenic probability.